RecruitingPhase 3NCT05253651
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Beaver, PA · Butler, PA · Erie, PA · +129 more sites